Illumina Hiseq 2500 drug

Aliases

HiSeq 2500, Hiseq 2500

External links

DrugBank · PubChem

Related entities (1)

Mentioned in (31)

Papers in which this entity is mentioned.

• GATA4/5/6 family transcription factors are conserved determinants of cardiac versus pharyngeal mesoderm fate. (2022)
• Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
• FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors. (2021)
• NGN2 induces diverse neuron types from human pluripotency. (2021)
• Programmed suppression of oxidative phosphorylation and mitochondrial function by gestational alcohol exposure correlate with widespread increases in H3K9me2 that do not suppress transcription. (2021)
• Simultaneous epigenetic perturbation and genome imaging reveal distinct roles of H3K9me3 in chromatin architecture and transcription. (2020)
• Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X. (2020)
• Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
• Kcnn2 blockade reverses learning deficits in a mouse model of fetal alcohol spectrum disorders. (2020)
• ASEP: Gene-based detection of allele-specific expression across individuals in a population by RNA sequencing. (2020)
• CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. (2019)
• The GenomeAsia 100K Project enables genetic discoveries across Asia. (2019)
• Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing. (2018)
• Genome-wide somatic variant calling using localized colored de Bruijn graphs. (2018)
• Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
• Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
• Integrating single-cell transcriptomic data across different conditions, technologies, and species. (2018)
• Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. (2017)
• Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Variations in brain defects result from cellular mosaicism in the activation of heat shock signalling. (2017)
• Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. (2017)
• Fragment Length of Circulating Tumor DNA. (2016)
• Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
• Integrative clinical genomics of advanced prostate cancer. (2015)
• Lead exposure induces changes in 5-hydroxymethylcytosine clusters in CpG islands in human embryonic stem cells and umbilical cord blood. (2015)
• Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. (2015)
• The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. (2015)
• TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. (2014)
• Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. (2012)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.